While RIP1 inhibition provided a similar benefit in anti-collagen antibody-induced arthritis model, there was no synergistic benefit in combining TNF and RIP1 inhibition (Patel et al., 2020). The gene discussed is RIPK1; the disease is arthritic joint disease.